Erxian decoction ameliorates myocardial tissue damage through activating PI3K/AKT signaling pathway in ovariectomized rats

Ying Yang,Haixia Liu,Jing Hu,Yujie Ma,Pei Li,Zhiguo Zhang,Yanjing Chen
DOI: https://doi.org/10.1080/07853890.2024.2411013
IF: 5.348
2024-10-11
Annals of Medicine
Abstract:Background Erxian decoction (EXD) is an empirical formula for treating cardiovascular disease, our previous work has shown that EXD could improve the cardiovascular structure and function in ovariectomized (OVX) rats, but its pharmacological mechanism is still unclear.
medicine, general & internal
What problem does this paper attempt to address?